Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients-Reference-Cited by-同舟云学术

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

Published:2020-04-28 Issue:12 Volume:51 Page:1353-1364
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kreijne Joany E.¹^ORCID,de Vries Annemarie C.¹,de Veer Rozanne C.¹,Bouma Gerd²,Dijkstra Gerard³,Voskuil Michiel D.³,West Rachel⁴,van Moorsel Sofia A. W.⁵,de Jong Dirk J.⁶,de Boer Nanne K.²,van der Woude C. Janneke¹,

Affiliation:

1. Department of Gastroenterology and Hepatology; Erasmus MC University Medical Center; Rotterdam The Netherlands

2. Department of Gastroenterology and Hepatology; Amsterdam UMC; Vrije Universiteit Amsterdam; AG&M Research Institute; Amsterdam The Netherlands

3. Department of Gastroenterology and Hepatology; University of Groningen and University Medical Center Groningen; Groningen The Netherlands

4. Department of Gastroenterology and Hepatology; Franciscus Gasthuis & Vlietland; Rotterdam The Netherlands

5. Department of Pharmacology; Zuyderland Medical Center; Heerlen-Sittard-Geleen The Netherlands

6. Department of Gastroenterology and Hepatology; Radboud University Medical Center; Nijmegen The Netherlands

Funder

Erasmus Medisch Centrum

Medical Research Advisory Committee

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15734/fullpdf

Reference41 articles.

1. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study;Eriksson;Gut,2019

2. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis;Timmer;Cochrane Database Syst Rev,2012

3. Reduced risk of inflammatory bowel disease-associated colorectal neoplasia with use of thiopurines: a systematic review and meta-analysis;Zhu;J Crohns Colitis,2018

4. Safety of thiopurines in the treatment of inflammatory bowel disease;Jong;Scand J Gastroenterol Suppl,2003

5. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice;Saibeni;Dig Liver Dis,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review;RMD Open;2024-01

2. Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy;Digestive Diseases and Sciences;2023-05-02

3. Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial;eClinicalMedicine;2022-03

4. Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules;Digestive Diseases and Sciences;2020-10-19

5. Letter: monitoring interval for thiopurine therapy - a comment;Alimentary Pharmacology & Therapeutics;2020-08-14